NDRA
ENDRA Life Sciences Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$6.05
+6.51%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.0x
Market Cap
$9.07M
MomentumView details →
1D Return
+6.51%
YTD Return
+32.89%
RSI (14)
62.7
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.0x
Market Cap
$9.07M
RSI (14)
62.7
MomentumView details →
1D Return
+6.51%
YTD Return
+32.89%
SummaryUpdated Jun 1, 2026
ENDRA Life Sciences Inc. (NASDAQ:NDRA) is a medical technology company founded in 2007 and based in Ann Arbor, Michigan. The company went public in June 2017 and focuses on developing advanced ultrasound imaging technology for medical diagnostics. ENDRA specializes in thermo-acoustic enhanced ultrasound (TAEUS) technology, which represents a novel approach to medical imaging that combines traditional ultrasound with photoacoustic principles to provide enhanced diagnostic capabilities for physicians.
Similar companies
Latest newsMore news →
ENDRA Life Sciences Inc. reported its financial results for the second quarter ended June 30, 2026.18d agoENDRA Life Sciences Inc. completed a private placement raising gross proceeds of $50 million, with net proceeds of $3.8 million.19d agoASP Isotopes proposed a merger with ENDRA Life Sciences.45d ago